Jupiter Neurosciences draws $1.86M second tranche from Yorkville SEPA; stockholder approval obtained

JUPITER NEUROSCIENCES, INC.

Second Pre-Paid Advance closing on Dec 23, 2025: $1,860,000 disbursed to Jupiter Neurosciences.
Issuance of convertible promissory note to Yorkville in exchange for the funds.
Stockholders approved issuance of shares exceeding 19.99% at annual meeting on Dec 19, 2025.
Registration statement on Form S-1 declared effective Dec 11, enabling resale of shares under SEPA.
Company retains right to direct Yorkville to purchase additional shares up to 100% of 5-day average daily trading volume.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.